TMPRSS2–ERG gene fusion status in minute (minimal) prostatic adenocarcinoma
Open Access
- 1 November 2009
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 22 (11), 1415-1422
- https://doi.org/10.1038/modpathol.2009.121
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Increased gene copy number of ERG on chromosome 21 but not TMPRSS2–ERG fusion predicts outcome in prostatic adenocarcinomasLaboratory Investigation, 2011
- TMPRSS2-ERG Gene Fusion Is Not Associated with Outcome in Patients Treated by ProstatectomyCancer Research, 2009
- TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomasLaboratory Investigation, 2009
- Pleiotropic Biological Activities of Alternatively Spliced TMPRSS2/ERG Fusion Gene TranscriptsCancer Research, 2008
- Gene Panel Model Predictive of Outcome in Men at High-Risk of Systemic Progression and Death From Prostate Cancer After Radical Retropubic ProstatectomyJournal of Clinical Oncology, 2008
- Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancersJournal of Clinical Pathology, 2007
- Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancerOncogene, 2007
- Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancerLaboratory Investigation, 2007
- Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate CancerScience, 2005
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998